Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: A systematic review of the literature

Surgical Endoscopy

Volumn 25, Issue 10, 2011, Pages 3127-3134

  Thijssen, Anthony S ^a   Broeders, Ivo A M J ^a   De Wit, G Ardine ^b,c   Draaisma, Werner A ^a  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cost effectiveness; GERD; Laparoscopy; Nissen; Proton pump inhibitors; Reflux

Indexed keywords

PROTON PUMP INHIBITOR;

COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HUMAN; LAPAROSCOPIC SURGERY; LONG TERM CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SCORING SYSTEM; SENSITIVITY ANALYSIS; STOMACH FUNDOPLICATION; SYSTEMATIC REVIEW; TREATMENT FAILURE; COST BENEFIT ANALYSIS; ECONOMICS; LAPAROSCOPY; METHODOLOGY; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; MODELS, ECONOMIC; PROTON PUMP INHIBITORS; QUALITY-ADJUSTED LIFE YEARS;

EID: 84856183203     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-011-1689-y     Document Type: Review

References (41)

1. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III (1997) Prevalence and clinical spectrum of gastro-oesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448-1456
2. Raiha IJ, Impivaara O, Seppala M, Sourander LB (1992) Prevalence and characteristics of symptomatic gastro-oesophageal reflux disease in the elderly. J Am Geriatr Soc 40:1209-1211
3. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR, Rodriguez-Artalejo F (2004) Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 19:95-105
4. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R (2000) Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J 113:178-181
5. Bruley Des Varannes S, Marek L, Humeau B, Humeau B, Lecasble M, Colin R (2006) Gastro-oesophageal reflux disease in primary care: prevalence, epidemiology and quality of life of patients. Gastroenterol Clin Biol 30:364-370
6. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P (2007) Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2:CD003244
7. Stylopoulos N, Rattner DW (2005) The history of hiatal hernia surgery: from Bowditch to laparoscopy. Ann Surg 241:185-193
8. Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Malm A, Sutherland I, Walan A (2007) Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 94:198-203
9. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastro-oesophageal reflux disease: followup of a randomized controlled trial. JAMA 285:2331-2338
10. Madan A, Minocha A (2006) Despite high satisfaction, majority of gastro-oesophageal reflux disease patients continue to use proton pump inhibitors after antireflux surgery. Aliment Pharmacol Ther 23:601-605
11. Drummond MF, Schulper M, Torrance G, O'Brien B, Stoddart G (2005) Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, Oxford
12. Centre for Evidence-Based Medicine, University of Oxford (2009) Levels of Evidence March 2009. http://www.cebm.net/index.aspx?o=1025. Accessed 1 Jun 2009
13. Coley CM, Barry MJ, Spechler SJ (1993) Initial medical versus surgical therapy for complicated or chronic gastro-oesophageal reflux disease (GORD): a cost-effectiveness analysis. Gastroenterology 104:A5
14. Hurley S, Mckeage S, Ngaei G (1996) Cost-effectiveness of primary medical therapy versus surgery for the treatment of gastro-oesophageal reflux disease (GORD). Aust J Hosp Pharm 26:171
15. Arguedas MR, Heudebert GR, Klapow JC, Centor RM, Eloubeidi MA, Wilcox CM, Spechler SJ (2004) Re-examination of the costeffectiveness of surgical versus medical therapy in patients with gastro-oesophageal reflux disease: the value of long-term data collection. Am J Gastroenterol 99:1023-1028
16. Comay D, Adam V, da Silveira EB, Kennedy W, Mayrand S, Barkun AN (2008) The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastro-oesophageal reflux disease: a cost-effectiveness analysis. Can J Gastroenterol 22:552-558
17. Epstein D, Bojke L, Sculpher MJ (2009) Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ 339:b2576
18. Romagnuolo J, Meier MA, Sadowski DC (2002) Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model. Ann Surg 236:191-202
19. Beck JR, Pauker SG (1983) The Markov process in medical prognosis. Med Decis Making 3:419-458
20. Peters MJ, Mukhtar A, Yunus RM, Khan S, Pappalardo J, Memon B, Memon MA (2009) Meta-analysis of randomized clinical trials comparing open and laparoscopic anti-reflux surgery. Am J Gastroenterol 104:1548-1561
21. Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhartde Jong HG, Broeders IA, Gooszen HG (2006) Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg 93:690-697
22. Rattner DW, Brooks DC (1995) Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 130:289-293
23. Heikkinen TJ, Haukipuro K, Koivukangas P, Sorasto A, Autio R, Södervik H, MäkeläH, Hulkko A (1999) Comparison of costs between laparoscopic and open Nissen fundoplication: a prospective randomized study with a 3-month followup. J Am Coll Surg 188:368-376
24. Incarbone R, Peters JH, Heimbucher J, Dvorak D, Bremner CG, DeMeester TR (1995) A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc 9:151-154
25. Low DE (1995) Examination of outcome and cost data of open and laparoscopic antireflux operations at Virginia Mason Medical Center in Seattle. Surg Endosc 9:1326-1328
26. Eshraghi N, Farahmand M, Soot SJ, Rand-Luby L, Deveney CW, Sheppard BC (1998) Comparison of outcomes of open versus laparoscopic Nissen fundoplication performed in a single practice. Am J Surg 175:371-374
27. Harewood GC, Gostout CJ (2003) Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor. Gastrointest Endosc 58:493-499
28. Wiersema MJ, Levy MJ (2004) Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor. Gastrointest Endosc 59:749-750
29. Chen D, Barber C, McLoughlin P, Thavaneswaran P, Jamieson GG, Maddern GJ (2009) Systematic review of endoscopic treatments for gastro-oesophageal reflux disease. Br J Surg 96: 128-136
30. Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Engström C (2009) Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clin Gastroenterol Hepatol 7:1292-1298
31. Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, Nuevo J (2009) Impact of gastro-oesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes 7:90
32. Myrvold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebak J (2001) The cost of long term therapy for gastrooesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut 49:488-494
33. Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, Macran S, Kilonzo M, Vale L, Francis J, Mowat A, Krukowski Z, Heading R, Thursz M, Russell I, Campbell M (2008) The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease-a UK collaborative study. Health Technol Assess 12:1-181
34. Bojke L, Hornby E, Sculpher M (2007) A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD. Pharmacoeconomics 25:829-841
35. Heudebert GR, Marks R, Wilcox CM, Centor RM (1997) Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology 112:1078-1086
36. Van Den Boom G, Go PM, Hameeteman W, Dallemagne B, Ament AJ (1996) Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastro-oesophageal reflux disease in the Netherlands. Scand J Gastroenterol 31:1-9
37. Viljakka M, Nevalainen J, Isolauri J (1997) Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastroenterol 32:766-772
38. Dire CA, Jones MP, Rulyak SJ, Kahrilas PJ (2003) The economics of laparoscopic Nissen fundoplication. Clin Gastroenterol Hepatol 1:328-332
39. Nessen SC, Holcomb J, Tonkinson B, Hetz SP, Schreiber MA (1999) Early laparoscopic Nissen fundoplication for recurrent reflux esophagitis: a cost-effective alternative to omeprazole. JSLS 3:103-106
40. Cookson R, Flood C, Koo B, Mahon D, Rhodes M (2005) Shortterm cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease. Br J Surg 92:700-706
41. Strate U, Emmermann A, Fibbe C, Layer P, Zornig C (2008) Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc 22:21-30